As of 2026-03-20, the Relative Valuation of Novavax Inc (NVAX) is 30.99 USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.74 USD, the upside of Novavax Inc based on Relative Valuation is 218.2%.
The range of the Relative Valuation is 19.25 - 48.24 USD.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 19.1x | 11.5x |
| Forward P/E multiples | 12.1x - 23.0x | 18.0x |
| Fair Price | 19.25 - 48.24 | 30.99 |
| Upside | 97.7% - 395.3% | 218.2% |
| Date | P/E |
| 2026-03-17 | 5.07 |
| 2026-03-16 | 4.81 |
| 2026-03-13 | 4.88 |
| 2026-03-12 | 4.91 |
| 2026-03-11 | 5.15 |
| 2026-03-10 | 5.10 |
| 2026-03-09 | 5.03 |
| 2026-03-06 | 4.76 |
| 2026-03-05 | 4.76 |
| 2026-03-04 | 4.72 |
| 2026-03-03 | 4.52 |
| 2026-03-02 | 4.82 |
| 2026-02-27 | 4.83 |
| 2026-02-26 | 5.34 |
| 2026-02-25 | 4.54 |
| 2026-02-24 | 4.51 |
| 2026-02-23 | 4.46 |
| 2026-02-20 | 4.39 |
| 2026-02-19 | 4.40 |
| 2026-02-18 | 4.14 |
| 2026-02-17 | 4.12 |
| 2026-02-13 | 4.15 |
| 2026-02-12 | 4.01 |
| 2026-02-11 | 4.28 |
| 2026-02-10 | 4.17 |
| 2026-02-09 | 4.15 |
| 2026-02-06 | 3.93 |
| 2026-02-05 | 3.75 |
| 2026-02-04 | 3.94 |
| 2026-02-03 | 3.99 |
| 2026-02-02 | 4.14 |
| 2026-01-30 | 4.22 |
| 2026-01-29 | 4.50 |
| 2026-01-28 | 4.40 |
| 2026-01-27 | 4.68 |
| 2026-01-26 | 4.59 |
| 2026-01-23 | 4.37 |
| 2026-01-22 | 4.65 |
| 2026-01-21 | 4.72 |
| 2026-01-20 | 3.91 |
| 2026-01-16 | 3.82 |
| 2026-01-15 | 3.71 |
| 2026-01-14 | 3.90 |
| 2026-01-13 | 4.13 |
| 2026-01-12 | 3.70 |
| 2026-01-09 | 3.47 |
| 2026-01-08 | 3.50 |
| 2026-01-07 | 3.63 |
| 2026-01-06 | 3.55 |
| 2026-01-05 | 3.46 |